Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 12/03/20011 min de lecture
Oral Dosage Form New Animal Drugs; Phenylbutazone Tablets and Boluses
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Phoenix Scientific, Inc. The supplemental NADA provides for oral use of a 200-milligram (mg) strength phenylbutazone tablet for relief of inflammatory conditions associated with the musculoskeletal system in dogs and horses.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →